Cargando…

Advanced glycation end products impair bone marrow mesenchymal stem cells osteogenesis in periodontitis with diabetes via FTO-mediated N(6)-methyladenosine modification of sclerostin

BACKGROUND: Diabetes mellitus (DM) and periodontitis are two prevalent diseases with mutual influence. Accumulation of advanced glycation end products (AGEs) in hyperglycemia may impair cell function and worsen periodontal conditions. N(6)-methyladenosine (m(6)A) is an important post-transcriptional...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jie, Zhu, Yanlin, Ai, Dongqing, Zhou, Mengjiao, Li, Han, Li, Guangyue, Zheng, Leilei, Song, Jinlin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625275/ https://www.ncbi.nlm.nih.gov/pubmed/37925419 http://dx.doi.org/10.1186/s12967-023-04630-5

Ejemplares similares

The Effect of Sclerostin and Monoclonal Sclerostin Antibody Romosozumab on Osteogenesis and Osteoclastogenesis Mediated by Periodontal Ligament Fibroblasts
por: Pigeaud, Karina E., et al.
Publicado: (2023)

Icaritin promotes the osteogenesis of bone marrow mesenchymal stem cells via the regulation of sclerostin expression
por: Wei, Qiushi, et al.
Publicado: (2020)

Icaritin promotes the osteogenesis of bone marrow mesenchymal stem cells via the regulation of sclerostin expression
por: Wei, Qiushi, et al.
Publicado: (2023)

Low-intensity pulsed ultrasound regulates osteoblast-osteoclast crosstalk via EphrinB2/EphB4 signaling for orthodontic alveolar bone remodeling
por: Zhou, Jie, et al.
Publicado: (2023)

Osteocyte TSC1 promotes sclerostin secretion to restrain osteogenesis in mice
por: Liu, Wen, et al.
Publicado: (2019)

Pyroptosis in periodontitis: From the intricate interaction with apoptosis, NETosis, and necroptosis to the therapeutic prospects
por: Xu, Xiaohui, et al.
Publicado: (2022)

LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2
por: Wang, Fan, et al.
Publicado: (2023)

Gender-Related Impact of Sclerostin Antibody on Bone in the Osteogenesis Imperfecta Mouse
por: Cardinal, Mickaël, et al.
Publicado: (2021)

Dental and periodontal phenotype in sclerostin knockout mice
por: Kuchler, Ulrike, et al.
Publicado: (2014)

Roles of N6‐Methyladenosine Demethylase FTO in Malignant Tumors Progression
por: Zheng, Qing-Kang, et al.
Publicado: (2021)

N(6)-methyladenosine RNA modification regulates strawberry fruit ripening in an ABA-dependent manner
por: Zhou, Leilei, et al.
Publicado: (2021)

Icariin Promotes the Osteogenesis of Bone Marrow Mesenchymal Stem Cells through Regulating Sclerostin and Activating the Wnt/β-Catenin Signaling Pathway
por: Gao, Jianliang, et al.
Publicado: (2021)

Effect of sclerostin inactivation in a mouse model of severe dominant osteogenesis imperfecta
por: Marulanda, Juliana, et al.
Publicado: (2023)

Expression of SOST/sclerostin in compressed periodontal ligament cells
por: Ueda, Masae, et al.
Publicado: (2016)

Sclerostin regulation: a promising therapy for periodontitis by modulating alveolar bone
por: Li, Tian-Jiao, et al.
Publicado: (2020)

Sclerostin Depletion Induces Inflammation in the Bone Marrow of Mice
por: Donham, Cristine, et al.
Publicado: (2021)

N6-methyladenosine demethylase FTO promotes growth and metastasis of gastric cancer via m(6)A modification of caveolin-1 and metabolic regulation of mitochondrial dynamics
por: Zhou, You, et al.
Publicado: (2022)

Deregulation of N6-Methyladenosine RNA Modification and Its Erasers FTO/ALKBH5 among the Main Renal Cell Tumor Subtypes
por: Guimarães-Teixeira, Catarina, et al.
Publicado: (2021)

Sclerostin-Mediated Impaired Osteogenesis by Fibroblast-Like Synoviocytes in the Particle-Induced Osteolysis Model
por: Jagga, Supriya, et al.
Publicado: (2021)

THU455 Sclerostin Inhibitor Use In The Medical Management Of Osteogenesis Imperfecta Type III
por: Lundholm, Michelle Diane, et al.
Publicado: (2023)

Sclerostin small-molecule inhibitors promote osteogenesis by activating canonical Wnt and BMP pathways
por: Sangadala, Sreedhara, et al.
Publicado: (2023)

N(6)-methyladenosine demethylases Alkbh5/Fto regulate cerebral ischemia-reperfusion injury
por: Xu, Kaiwei, et al.
Publicado: (2020)

N(6)-Methyladenosine in Nuclear RNA is a Major Substrate of the Obesity-Associated FTO
por: Jia, Guifang, et al.
Publicado: (2011)

N6‐methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO‐PGC‐1α signalling axis
por: Zhuang, Changshui, et al.
Publicado: (2019)

AMPK regulates lipid accumulation in skeletal muscle cells through FTO-dependent demethylation of N(6)-methyladenosine
por: Wu, Weiche, et al.
Publicado: (2017)

FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis
por: Zhao, Xu, et al.
Publicado: (2014)

Irisin Promotes Osteogenesis by Modulating Oxidative Stress and Mitophagy through SIRT3 Signaling under Diabetic Conditions
por: Li, Guangyue, et al.
Publicado: (2022)

Gene Expression Profile and Acute Gene Expression Response to Sclerostin Inhibition in Osteogenesis Imperfecta Bone
por: Surowiec, Rachel K, et al.
Publicado: (2020)

A novel inhibitor of N(6)-methyladenosine demethylase FTO induces mRNA methylation and shows anti-cancer activities
por: Xie, Guoyou, et al.
Publicado: (2022)

Fat mass and obesity associated (FTO)-mediated N6-methyladenosine modification of Krüppel-like factor 3 (KLF3) promotes osteosarcoma progression
por: Shan, Hong-Jian, et al.
Publicado: (2022)

Gingival crevicular fluid levels of sclerostin in chronic periodontitis and healthy subjects
por: Rezaei Esfahrood, Zeinab, et al.
Publicado: (2018)

Sclerostin antibody stimulates periodontal regeneration in large alveolar bone defects
por: Yao, Yao, et al.
Publicado: (2020)

N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability
por: Zou, Libin, et al.
Publicado: (2022)

Sclerostin
por: Silverman, Stuart L.
Publicado: (2010)

RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3
por: Niu, Yi, et al.
Publicado: (2019)

Fat mass and obesity-associated factor (FTO)-mediated N6-methyladenosine regulates spermatogenesis in an age-dependent manner
por: Wu, Yifei, et al.
Publicado: (2023)

Pan-Cancer Analysis of the N6-Methyladenosine Eraser FTO as a Potential Prognostic and Immunological Biomarker
por: Zhao, Chengwen, et al.
Publicado: (2021)

Nitric oxide inhibits FTO demethylase activity to regulate N(6)-methyladenosine mRNA methylation
por: Kuschman, Hannah Petraitis, et al.
Publicado: (2023)

Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
por: van Dinther, Maarten, et al.
Publicado: (2013)

Methyladenosine Modification in RNAs: Classification and Roles in Gastrointestinal Cancers
por: Li, Qinghai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ajfs9n9vbl487icm2n5jmsvl5j